abc biopply AG provides validated highly predictive preclinical CRO services for drug efficacy, safety, toxicity, resistance, and biomarker development based on its proprietary 3D CoSeedis humanized multi-organoid assays™ on clinically relevant disease models (e.g. oncology, neurology, hepatic etc.)
Products, services, technology
abc biopply provide preclinical CRO services to support project partners from pharma and biotech during development of next-generation drug pipelines, personalized medicine solutions, immunotherapy models, and AI-based phenotypic analysis. We bring a strong expertise and 400m² fully equipped labs.
- https://biopply.com
- +41 79 434 10 49
- Send an email
- Dr. Arne Faisst
